Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Karishma, Valand"'
Autor:
Alastair Magness, Emma Colliver, Katey S. S. Enfield, Claudia Lee, Masako Shimato, Emer Daly, David A. Moore, Monica Sivakumar, Karishma Valand, Dina Levi, Crispin T. Hiley, Philip S. Hobson, Febe van Maldegem, James L. Reading, Sergio A. Quezada, Julian Downward, Erik Sahai, Charles Swanton, Mihaela Angelova
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-20 (2024)
Abstract The growing scale and dimensionality of multiplexed imaging require reproducible and comprehensive yet user-friendly computational pipelines. TRACERx-PHLEX performs deep learning-based cell segmentation (deep-imcyto), automated cell-type ann
Externí odkaz:
https://doaj.org/article/f61b4b8bd2f54cbd9679706490019396
Autor:
Febe van Maldegem, Karishma Valand, Megan Cole, Harshil Patel, Mihaela Angelova, Sareena Rana, Emma Colliver, Katey Enfield, Nourdine Bah, Gavin Kelly, Victoria Siu Kwan Tsang, Edurne Mugarza, Christopher Moore, Philip Hobson, Dina Levi, Miriam Molina-Arcas, Charles Swanton, Julian Downward
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
The tumour microenvironment (TME) may change in response to cancer treatments such as KRAS G12C inhibition, with potential implications for combination therapies. Here, the authors provide an antibody panel and workflow for analysing the TME with ima
Externí odkaz:
https://doaj.org/article/c85c11c742864408a99b5e94e13e53db
Autor:
Edurne Mugarza, Febe van Maldegem, Jesse Boumelha, Christopher Moore, Sareena Rana, Miriam Llorian Sopena, Philip East, Rachel Ambler, Panayiotis Anastasiou, Pablo Romero-Clavijo, Karishma Valand, Megan Cole, Miriam Molina-Arcas, Julian Downward
Publikováno v:
Science Advances, 8(29):eabm8780. American Association for the Advancement of Science
Mugarza, E, van Maldegem, F, Boumelha, J, Moore, C, Rana, S, Llorian Sopena, M, East, P, Ambler, R, Anastasiou, P, Romero-Clavijo, P, Valand, K, Cole, M, Molina-Arcas, M & Downward, J 2022, ' Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers ', Science Advances, vol. 8, no. 29, eabm8780, pp. eabm8780 . https://doi.org/10.1126/sciadv.abm8780
Mugarza, E, van Maldegem, F, Boumelha, J, Moore, C, Rana, S, Llorian Sopena, M, East, P, Ambler, R, Anastasiou, P, Romero-Clavijo, P, Valand, K, Cole, M, Molina-Arcas, M & Downward, J 2022, ' Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers ', Science Advances, vol. 8, no. 29, eabm8780, pp. eabm8780 . https://doi.org/10.1126/sciadv.abm8780
Recently developed KRAS G12C inhibitory drugs are beneficial to lung cancer patients harboring KRAS G12C mutations, but drug resistance frequently develops. Because of the immunosuppressive nature of the signaling network controlled by oncogenic KRAS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eba7ee317fefd79fc260d98ab44b82c
https://research.vumc.nl/en/publications/8bed69b7-11f1-4db0-bb5b-f054048a8ab8
https://research.vumc.nl/en/publications/8bed69b7-11f1-4db0-bb5b-f054048a8ab8
Autor:
Edurne, Mugarza, Febe, van Maldegem, Jesse, Boumelha, Christopher, Moore, Sareena, Rana, Miriam, Llorian Sopena, Philip, East, Rachel, Ambler, Panayiotis, Anastasiou, Pablo, Romero-Clavijo, Karishma, Valand, Megan, Cole, Miriam, Molina-Arcas, Julian, Downward
Publikováno v:
Science advances. 8(29)
Recently developed KRAS
Autor:
Megan Cole, Jesse Boumelha, Miriam Llorian Sopena, Miriam Molina-Arcas, Panos Anastasiou, Sareena Rana, Christopher I. Moore, Febe van Maldegem, Philip East, Julian Downward, Edurne Mugarza, Karishma Valand, Pablo Romero Clavijo, Rachel Ambler
The recent development and approval of KRASG12C inhibitors promises to change profoundly the clinical management of lung cancer patients harbouring KRASG12C mutations. However, early clinical data indicate that acquired drug resistance can frequently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eebd4728b44a095dd96a3a4fd4745a56
https://doi.org/10.1101/2021.10.18.464819
https://doi.org/10.1101/2021.10.18.464819
Autor:
Dina Levi, Nourdine Bah, K. Enfield, Karishma Valand, Emma Colliver, Miriam Molina-Arcas, Philip Hobson, Julian Downward, Febe van Maldegem, Sareena Rana, Edurne Mugarza, Charles Swanton, Christopher I. Moore, Mihaela Angelova, Megan Cole, Victoria Siu Kwan Tsang, Harshil Patel
Mouse models are critical in pre-clinical studies of cancer therapy, allowing dissection of mechanisms through chemical and genetic manipulations that are not feasible in the clinical setting. In studies of the tumour microenvironment (TME), novel hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e25dd7b585d515f3d1b8f8365e3a98cd
https://doi.org/10.21203/rs.3.rs-301541/v1
https://doi.org/10.21203/rs.3.rs-301541/v1
Publikováno v:
biorxiv
Autor:
Sareena Rana, Edurne Mugarza, Christopher I. Moore, Pablo Romero-Clavijo, F. Van Maldegem, Miriam Molina-Arcas, Julian Downward, Megan Cole, Jesse Boumelha, Karishma Valand
Publikováno v:
European Journal of Cancer. 138:S60
Autor:
Karishma Valand, Febe van Maldegem, Philip Hobson, Julian Downward, Deborah R. Caswell, Edurne Mugarza, Victoria Siu Kwan Tsang
Publikováno v:
Cancer Immunology Research. 7:A160-A160
With the advancement of immunotherapies for lung cancer, it has become apparent how insufficient our knowledge is surrounding the interactions between the tumor and the immune system. In particular in the context of combining immunotherapy with conve